10x Genomics (TXG) Other Accumulated Expenses (2018 - 2026)

10x Genomics has reported Other Accumulated Expenses for 9 years, with the latest figure at $8.4 million in Q1 2026.

• Quarterly Other Accumulated Expenses fell 31.42% year-over-year to $8.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.4 million (down 31.42% YoY) and the FY2025 annual result came in at $11.0 million, up 99.51% from the prior year.
• Other Accumulated Expenses retreated to $8.4 million in Q1 2026 per TXG's latest filing, from $11.0 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $12.8 million in Q2 2025 and troughed at $3.3 million in Q2 2023.
• A 5-year average of $7.2 million and a median of $5.7 million in 2024 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2022 and 2023: Other Accumulated Expenses soared 2398.98% in 2022, then plunged 34.2% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $6.7 million in 2022, then sank by 34.2% to $4.4 million in 2023, then grew by 24.88% to $5.5 million in 2024, then soared by 99.51% to $11.0 million in 2025, then decreased by 23.28% to $8.4 million in 2026.
• According to Business Quant data, Other Accumulated Expenses over the past three periods registered $8.4 million, $11.0 million, and $12.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.